San Diego, California, United States · On-site
$110k–$135k/yr
We are seeking a highly motivated and scientifically rigorous Scientist to join the Analytical Development team to support the development and validation of analytical methods for Kenai Therapeutic’s programs from early …
Skills: Multi-color Flow Cytometry, Assay Development, Method Validation, Data Analysis, Cell Culture
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Scientist will design, optimize, and validate multi-color flow cytometry assays to support the characterization and release of product pipelines. They will also manage cell lines, generate technical reports, and collaborate with cross-functional teams and external CROs.
Requires a Ph.D. with 2-5 years or an M.S. with 6+ years of industry experience in analytical development and deep expertise in multiparameter flow cytometry. Candidates must be proficient in ICH guidelines, cell handling, and advanced data analysis platforms like FlowJo.
We are seeking a highly motivated and scientifically rigorous Scientist to join the Analytical Development team to support the development and validation of analytical methods for Kenai Therapeutic’s programs from early development through to commercial launch. This position is focused on the development, optimization and validation of flow cytometry assays to support critical activities associated with characterization and release of Kenai Therapeutic’s product pipelines. The Scientist will work closely within the CMC team to consistently deliver quality data by maintaining continuous operations of flow cytometry related activities. The candidate will have expertise in multi-color flow cytometry assay design and development, data analysis and presentation, robust experience with digital flow cytometry instrumentation operation and maintenance, and good documentation practices for project execution in a fast-paced biotech environment. This role is on-site in San Diego, CA and reports to the Director of Analytical Development.
Responsibilities
Required Qualifications
Preferred Qualifications
The salary range for this position is $110,000 USD to $135,000 USD annually. This salary range is an estimate, and the actual salary may vary based on experience and/or the Company’s compensation practices.
Pioneering next generation approaches to cure neurological conditions
Kenai Therapeutics is a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions. By leveraging a proprietary, Nobel Prize-winning iPSC platform, Kenai is developing off-the-shelf, allogeneic neuron replacement and gene-modified cell therapies designed to be disease-modifying. Kenai’s lead candidate, RNDP-001, is in Phase 1 clinical development for moderate to moderate-severe forms of idiopathic Parkinson’s disease. The company’s additional programs target inherited and genetically driven subtypes of Parkinson’s disease and other neurological conditions, with the goal of delivering long-lasting restoration of function. Kenai’s exclusive manufacturing partnership with FUJIFILM Cellular Dynamics, Inc., enables scalable, cryopreserved production of high-potency cell therapies. Founded in 2022, Kenai is backed by leading life science investors and is headquartered in San Diego, CA.
Offices: San Diego, California, US · Cambridge, MA, US
Pioneering next generation approaches to cure neurological conditions
Kenai Therapeutics is a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions. By leveraging a proprietary, Nobel Prize-winning iPSC platform, Kenai is developing off-the-shelf, allogeneic neuron replacement and gene-modified cell therapies designed to be disease-modifying. Kenai’s lead candidate, RNDP-001, is in Phase 1 clinical development for moderate to moderate-severe forms of idiopathic Parkinson’s disease. The company’s additional programs target inherited and genetically driven subtypes of Parkinson’s disease and other neurological conditions, with the goal of delivering long-lasting restoration of function. Kenai’s exclusive manufacturing partnership with FUJIFILM Cellular Dynamics, Inc., enables scalable, cryopreserved production of high-potency cell therapies. Founded in 2022, Kenai is backed by leading life science investors and is headquartered in San Diego, CA.
Offices: San Diego, California, US · Cambridge, MA, US
